Finance

Lists
VTR:NYSE
Ventas Inc
USD 82,87
+1,37%
(+1,12) 1D
9 Okt., 13:13:37 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VTR...
Open
USD 81,72
High
USD 82,87
Low
USD 81,33
Mkt. cap
42,50 mjd
Avg. vol.
3,76 m
Volume
1,61 m
Dividend
2,46%
Quarterly dividend
USD 0,51
Ex-dividend date
30 Sep. 2026
P/E ratio
152,04
52-wk high
USD 101,60
52-wk low
USD 66,92
EPS
USD 0,55
Beta
0,71
Shares outstanding
512,95 m
No. of employees
542
Open
USD 81,72
High
USD 82,87
Low
USD 81,33
Mkt. cap
42,50 mjd
Avg. vol.
3,76 m
Volume
1,61 m
Dividend
2,46%
Quarterly dividend
USD 0,51
Ex-dividend date
30 Sep. 2026
P/E ratio
152,04
52-wk high
USD 101,60
52-wk low
USD 66,92
EPS
USD 0,55
Beta
0,71
Shares outstanding
512,95 m
No. of employees
542
News stories
From web sources and news partners
Investing.com India
Investing.com India
·
1 dag gelede
Form 4 Ventas Inc For: 7 October By Investing.com
Profile
Ventas, Inc. is a real estate investment trust specializing in the ownership and management of research, medicine and healthcare facilities in the United States, Canada and the United Kingdom. As of December 2019, the group's portfolio consisted of 1,200 properties divided among nursing homes, medical office buildings, rehabilitation and acute care centres, special care centres, laboratories and research centres and medical-surgical centres for a total value of nearly $25 billion. As of 2019, it is a Fortune 1000 corporation. Wikipedia
About Ventas Inc
CEODebra Cafaro
Employees542
Founded1983
HeadquartersChicago, Illinois, Verenigde State van Amerika
SectorReal estate investment trust
Analyst ratings
Based on 15 analysts giving stock ratings to VTR in the past 3 months
Buy
Buy
11
Hold
4
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for VTR in the last 3 months.
Highest
Current USD 82,87
USD 113,00 (+36,36%)
Average
USD 99,93 (+20,59%)
Lowest
USD 72,00 (-13,12%)
Analyst
Recommendation
Action
Price target
Projected
Date
Juan C. Sanabria
BMO Capital
Buy
Reiterated
USD 107,00
+29,1%
10/02/2026
James Kammert
Evercore ISI
Buy
Maintained
USD 100,00
+20,7%
09/21/2026
Julien Blouin
Goldman Sachs
Buy
Maintained
USD 112,00
+35,2%
09/16/2026
Joe Dickstein
Jefferies
Buy
Initiated
USD 102,00
+23,1%
09/15/2026
Michael Mueller
J.P. Morgan
Buy
Maintained
USD 104,00
+25,5%
09/03/2026
Nicholas Yulico
Scotiabank
Hold
Maintained
USD 95,00
+14,6%
09/02/2026
John Kilichowski
Wells Fargo
Buy
Reiterated
USD 104,00
+25,5%
09/01/2026
Richard Hightower
Barclays
Hold
Maintained
USD 102,00
+23,1%
08/31/2026
Michael Goldsmith
UBS
Hold
Reiterated
USD 93,00
+12,2%
08/21/2026
Michael Carroll
RBC Capital
Buy
Reiterated
USD 99,00
+19,5%
08/14/2026
Ronald Kamdem
Morgan Stanley
Hold
Reiterated
USD 90,00
+8,6%
08/13/2026
Nicholas Joseph
Citi
Buy
Maintained
USD 72,00
-13,1%
08/04/2026
Jeffrey Spector
Bank of America Securities
Buy
Reiterated
USD 113,00
+36,4%
08/03/2026
Richard Anderson
Cantor Fitzgerald
Buy
Reiterated
USD 102,00
+23,1%
07/31/2026
Vikram Malhotra
Mizuho Securities
Buy
Maintained
USD 104,00
+25,5%
07/22/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
USD 114,00
+37,6%
07/15/2026
Unknown Analyst
Raymond James
Buy
Initiated
USD 94,00
+13,4%
06/16/2026
Dave Rodgers
Raymond James
Buy
Initiated
USD 94,00
+13,4%
06/16/2026
Omotayo Okusanya
Deutsche Bank
Buy
Maintained
USD 100,00
+20,7%
06/16/2026
Jonathan Petersen
Jefferies
Buy
Maintained
USD 100,00
+20,7%
05/12/2026
Austin Wurschmidt
KeyBanc
Buy
Maintained
USD 95,00
+14,6%
05/07/2026
Marie Ferguson
Argus Research
Buy
Maintained
USD 88,00
+6,2%
02/09/2026
Last report
30 Jul. 2026
Fiscal period
Q2 2026
USD 0,17 / USD 0,11
+51,73%beat
Revenue / Est. (USD)
1,72 mjd / 1,69 mjd
+1,92%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,50 mjd
1,55 mjd
1,65 mjd
1,72 mjd
Cost of goods sold
869,92 m
937,40 m
1,00 mjd
1,04 mjd
Cost of revenue
869,92 m
937,40 m
1,00 mjd
1,04 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
40,39 m
41,01 m
62,75 m
46,99 m
Operating expense
397,56 m
297,53 m
416,91 m
422,70 m
Total operating expenses
1,27 mjd
1,23 mjd
1,42 mjd
1,47 mjd
Operating income
233,98 m
315,49 m
226,81 m
254,70 m
Other non operating income
-13,37 m
-4,20 m
-9,70 m
-4,45 m
EBT including unusual items
62,36 m
71,87 m
43,11 m
46,60 m
EBT excluding unusual items
66,67 m
164,69 m
63,47 m
91,99 m
Income tax expense
-6,34 m
-1,12 m
-15,94 m
-25,62 m
Effective tax rate
-10,17%
-1,56%
-36,97%
-54,97%
Other operating expenses
-
-
-
-
Net income
66,05 m
70,20 m
55,91 m
70,57 m
Net profit margin
4,40%
4,53%
3,39%
4,10%
Earnings per share
0,12
0,13
0,10
0,17
Interest and investment income
4,18 m
7,88 m
2,50 m
1,78 m
Interest expense
-158,12 m
-154,47 m
-156,14 m
-160,03 m
Net interest expenses
-153,94 m
-146,59 m
-153,64 m
-158,26 m
Depreciation and amortization charges
357,17 m
256,52 m
354,17 m
375,71 m
EBITDA
559,73 m
659,02 m
585,75 m
633,56 m
Gain or loss from assets sale
-1,28 m
-3,31 m
-15,06 m
-174,00 k
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme